KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Gross Margin (2016 - 2025)

Idexx Laboratories has reported Gross Margin over the past 17 years, most recently at 60.35% for Q4 2025.

  • Quarterly results put Gross Margin at 60.35% for Q4 2025, up 55.0% from a year ago — trailing twelve months through Dec 2025 was 61.8% (up 76.0% YoY), and the annual figure for FY2025 was 61.8%, up 76.0%.
  • Gross Margin for Q4 2025 was 60.35% at Idexx Laboratories, down from 61.83% in the prior quarter.
  • Over the last five years, Gross Margin for IDXX hit a ceiling of 62.62% in Q2 2025 and a floor of 56.97% in Q4 2021.
  • Median Gross Margin over the past 5 years was 60.26% (2023), compared with a mean of 60.19%.
  • Biggest five-year swings in Gross Margin: soared 312bps in 2021 and later tumbled -91bps in 2022.
  • Idexx Laboratories' Gross Margin stood at 56.97% in 2021, then grew by 3bps to 58.53% in 2022, then dropped by 0bps to 58.36% in 2023, then grew by 2bps to 59.8% in 2024, then increased by 1bps to 60.35% in 2025.
  • The last three reported values for Gross Margin were 60.35% (Q4 2025), 61.83% (Q3 2025), and 62.62% (Q2 2025) per Business Quant data.